L-Carnitine is a conditionally essential amino-acid derivative required for transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation and ATP production. At 600 mg/mL, LC-600 delivers clinically meaningful doses in low injection volumes, improving compliance and protocol efficiency.
Shuttles long-chain fatty acids across mitochondrial membrane, enables β-oxidation, prevents cytosolic fatty acid accumulation. Improved fat utilization and energy production.
Enhanced ATP generation, reduced reliance on glycolysis, improved metabolic flexibility. Greater stamina, endurance, reduced fatigue.
Reduced lactate buildup, improved recovery, enhanced ammonia clearance.
Improved skeletal muscle glucose uptake, insulin signaling efficiency, metabolic adaptability during caloric restriction.
Neuronal energy metabolism, cognitive clarity, mood stability, mental fatigue reduction.
Fat oxidation, lean mass preservation, improved metabolic rate. Used alongside GLP-1 agonists, LC-series blends, caloric-deficit programs.
Improved endurance, faster post-exercise recovery, reduced muscle soreness.
Chronic fatigue patterns, post-viral fatigue, mitochondrial dysfunction, burnout syndromes.
Glucose utilization, fat metabolism, improved metabolic markers.
Sperm motility, testicular mitochondrial function, hormonal health (indirect, adjunctive).
| Dose | Volume |
|---|---|
| 300 mg | 0.5 mL |
| 600 mg | 1.0 mL |
| 1,200 mg | 2.0 mL |
| 1,800 mg | 3.0 mL |
| 2,400 mg | 4.0 mL |
Large volumes may be split between injection sites.
Fatigue or low energy? → Yes
Difficulty losing fat? → Yes
Poor exercise recovery? → Yes
Insulin resistance? → Consider
Severe renal disease? → Avoid or reduce dose
General wellness → 500–1,000 mg weekly
Weight loss → 1,000–2,000 mg weekly
Performance → 1,000–2,000 mg pre/post training
Fatigue syndromes → 500–1,000 mg 2×/week
Typically mild/dose-dependent: injection-site discomfort, mild nausea, fishy body odor (rare, high doses), headache, restlessness.
This document is provided solely for educational and informational purposes. LC-600 is a compounded nutrient-based formulation not FDA-approved for weight loss or metabolic treatment. Peptide Protocol Portal makes no representations or warranties. By using this document, the reader agrees that Peptide Protocol Portal shall not be held liable. Use at your own risk.